UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2022
Commission file number: 001-40231
Universe Pharmaceuticals INC
265 Jingjiu Avenue
Jinggangshan Economic and Technological Development Zone
Ji’an, Jiangxi, China 343100
+86-0796-8403309
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F
☐
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Explanatory Note
Universe Pharmaceuticals INC (the “Registrant”) is filing this
current report on Form 6-K to report its financial results for the
six months ended August 16, 2022 and to discuss its recent
corporate developments.
Attached as exhibits to this current report on Form 6-K are:
|
(1) |
the
unaudited condensed interim consolidated financial statements and
related notes as Exhibit 99.1; |
|
|
|
|
(2) |
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations as Exhibit 99.2; |
|
|
|
|
(3) |
a
press release dated August 12, 2022, titled “Universe
Pharmaceuticals INC Reports Financial Results for The First Six
Months of Fiscal Year 2022” as Exhibit 99.3; and |
|
|
|
|
(4) |
Interactive
Data File disclosure as Exhibit 101 in accordance with Rule 405 of
Regulation S-T. |
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Statements in this current report with respect to the Company’s
current plans, estimates, strategies and beliefs and other
statements that are not historical facts are forward-looking
statements about the future performance of the Company.
Forward-looking statements include, but are not limited to, those
statements using words such as “believe,” “expect,” “plans,”
“strategy,” “prospects,” “forecast,” “estimate,” “project,”
“anticipate,” “aim,” “intend,” “seek,” “may,” “might,” “could” or
“should,” and words of similar meaning in connection with a
discussion of future operations, financial performance, events or
conditions. From time to time, oral or written forward-looking
statements may also be included in other materials released to the
public. These statements are based on management’s assumptions,
judgments and beliefs in light of the information currently
available to it. The Company cautions investors that a number of
important risks and uncertainties could cause actual results to
differ materially from those discussed in the forward-looking
statements, including but not limited to, product and service
demand and acceptance, changes in technology, economic conditions,
the impact of competition and pricing, government regulation, and
other risks contained in reports filed by the company with the U.S.
Securities and Exchange Commission. Therefore, investors should not
place undue reliance on such forward-looking statements. Actual
results may differ significantly from those set forth in the
forward-looking statements.
All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the company, are expressly
qualified by the cautionary statements and any other cautionary
statements which may accompany the forward-looking statements. In
addition, the company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after
the date hereof.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
|
Universe
Pharmaceuticals INC. |
|
|
Date:
August 16, 2022 |
By: |
/s/
Gang Lai |
|
|
Gang
Lai |
|
|
Chief
Executive Officer |
4
false --09-30 2022-03-31 0001809616
0001809616 2021-10-01 2022-03-31 0001809616 2022-03-31 0001809616
2021-09-30 0001809616 2020-10-01 2021-03-31 0001809616
us-gaap:CommonStockMember 2020-09-30 0001809616
us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001809616
upc:SubscriptionReceivableMember 2020-09-30 0001809616
upc:StatutoryReservesMember 2020-09-30 0001809616
us-gaap:RetainedEarningsMember 2020-09-30 0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30
0001809616 2020-09-30 0001809616 us-gaap:CommonStockMember
2020-10-01 2021-03-31 0001809616
us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2021-03-31
0001809616 upc:SubscriptionReceivableMember 2020-10-01 2021-03-31
0001809616 upc:StatutoryReservesMember 2020-10-01 2021-03-31
0001809616 us-gaap:RetainedEarningsMember 2020-10-01 2021-03-31
0001809616 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-10-01 2021-03-31 0001809616 us-gaap:CommonStockMember
2021-03-31 0001809616 us-gaap:AdditionalPaidInCapitalMember
2021-03-31 0001809616 upc:SubscriptionReceivableMember 2021-03-31
0001809616 upc:StatutoryReservesMember 2021-03-31 0001809616
us-gaap:RetainedEarningsMember 2021-03-31 0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31
0001809616 2021-03-31 0001809616 us-gaap:CommonStockMember
2021-09-30 0001809616 us-gaap:AdditionalPaidInCapitalMember
2021-09-30 0001809616 upc:SubscriptionReceivableMember 2021-09-30
0001809616 upc:StatutoryReservesMember 2021-09-30 0001809616
us-gaap:RetainedEarningsMember 2021-09-30 0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30
0001809616 us-gaap:CommonStockMember 2021-10-01 2022-03-31
0001809616 us-gaap:AdditionalPaidInCapitalMember 2021-10-01
2022-03-31 0001809616 upc:SubscriptionReceivableMember 2021-10-01
2022-03-31 0001809616 upc:StatutoryReservesMember 2021-10-01
2022-03-31 0001809616 us-gaap:RetainedEarningsMember 2021-10-01
2022-03-31 0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01
2022-03-31 0001809616 us-gaap:CommonStockMember 2022-03-31
0001809616 us-gaap:AdditionalPaidInCapitalMember 2022-03-31
0001809616 upc:SubscriptionReceivableMember 2022-03-31 0001809616
upc:StatutoryReservesMember 2022-03-31 0001809616
us-gaap:RetainedEarningsMember 2022-03-31 0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31
0001809616 upc:UniverseHKMember 2021-10-01 2022-03-31 0001809616
upc:UniverseIncMember 2022-03-31 0001809616
upc:UniverseTechnologyMember 2022-03-31 0001809616
upc:UniverseTechnologyMember 2019-12-01 2019-12-31 0001809616
upc:JiangxiUniverseMember 2021-10-01 2022-03-31 0001809616
upc:UniverseTradeMember 2022-03-31 0001809616 upc:JiangxiMember
2022-03-31 0001809616 2021-03-25 0001809616
us-gaap:OverAllotmentOptionMember 2021-03-29 0001809616 2021-03-25
2021-03-25 0001809616 us-gaap:OverAllotmentOptionMember 2021-03-25
2021-03-25 0001809616 upc:UniverseIncMember 2021-10-01 2022-03-31
0001809616 upc:UniverseHKMember 2021-10-01 2022-03-31 0001809616
upc:UniverseHKMember 2022-03-31 0001809616
upc:UniverseTechnologyMember 2021-10-01 2022-03-31 0001809616
upc:UniverseTechnologyMember 2022-03-31 0001809616
upc:JiangxiUniverseMember 2021-10-01 2022-03-31 0001809616
upc:JiangxiUniverseMember 2022-03-31 0001809616
upc:UniverseTradeMember 2021-10-01 2022-03-31 0001809616
upc:UniverseHanheMember 2021-10-01 2022-03-31 0001809616
upc:UniverseHanheMember 2022-03-31 0001809616 2020-10-01 2021-09-30
0001809616 upc:UniversePharmaceuticalsINCMember 2022-03-31
0001809616 upc:JxRcbBankMember 2021-10-01 2022-03-31 0001809616
upc:JxRcbBankMember 2022-03-31 0001809616
us-gaap:OtherLongTermInvestmentsMember 2021-10-01 2022-03-31
0001809616 us-gaap:OtherLongTermInvestmentsMember 2020-10-01
2021-09-30 0001809616 pf0:MinimumMember 2018-04-25 2018-05-01
0001809616 pf0:MinimumMember 2019-03-25 2019-04-01 0001809616
us-gaap:BuildingMember 2021-10-01 2022-03-31 0001809616
pf0:MinimumMember us-gaap:MachineryAndEquipmentMember 2021-10-01
2022-03-31 0001809616 pf0:MaximumMember
us-gaap:MachineryAndEquipmentMember 2021-10-01 2022-03-31
0001809616 pf0:MinimumMember us-gaap:AutomobilesMember 2021-10-01
2022-03-31 0001809616 pf0:MaximumMember us-gaap:AutomobilesMember
2021-10-01 2022-03-31 0001809616 pf0:MinimumMember
upc:OfficeAndElectricEquipmentMember 2021-10-01 2022-03-31
0001809616 pf0:MaximumMember upc:OfficeAndElectricEquipmentMember
2021-10-01 2022-03-31 0001809616 us-gaap:UseRightsMember 2021-10-01
2022-03-31 0001809616 us-gaap:ComputerSoftwareIntangibleAssetMember
2021-10-01 2022-03-31 0001809616 upc:LessThan3MonthsMember
2022-03-31 0001809616 upc:LessThan3MonthsMember 2021-10-01
2022-03-31 0001809616 upc:From4To6MonthsMember 2022-03-31
0001809616 upc:From4To6MonthsMember 2021-10-01 2022-03-31
0001809616 upc:From7To9MonthsMember 2022-03-31 0001809616
upc:From7To9MonthsMember 2021-10-01 2022-03-31 0001809616
upc:From10To12MonthsMember 2022-03-31 0001809616
upc:From10To12MonthsMember 2021-10-01 2022-03-31 0001809616
upc:Over1YearMember 2022-03-31 0001809616 upc:Over1YearMember
2021-10-01 2022-03-31 0001809616 2021-09-01 2021-09-06 0001809616
2021-09-06 0001809616 us-gaap:BuildingMember 2022-03-31 0001809616
us-gaap:BuildingMember 2021-09-30 0001809616
us-gaap:MachineryAndEquipmentMember 2022-03-31 0001809616
us-gaap:MachineryAndEquipmentMember 2021-09-30 0001809616
us-gaap:AutomobilesMember 2022-03-31 0001809616
us-gaap:AutomobilesMember 2021-09-30 0001809616
upc:OfficeAndElectricEquipmentMember 2022-03-31 0001809616
upc:OfficeAndElectricEquipmentMember 2021-09-30 0001809616
us-gaap:ConstructionInProgressMember 2022-03-31 0001809616
us-gaap:ConstructionInProgressMember 2021-09-30 0001809616
us-gaap:UseRightsMember 2022-03-31 0001809616
us-gaap:UseRightsMember 2021-09-30 0001809616
us-gaap:ComputerSoftwareIntangibleAssetMember 2022-03-31 0001809616
us-gaap:ComputerSoftwareIntangibleAssetMember 2021-09-30 0001809616
upc:AmortizationExpenseMember 2022-03-31 0001809616
us-gaap:ConstructionInProgressMember
2021-06-25 0001809616 upc:ChenyuanMember 2022-03-31 0001809616
us-gaap:ConstructionInProgressMember upc:ChenyuanMember 2022-03-31
0001809616 upc:CapitalExpenditureMember 2022-03-31 0001809616
upc:MrGangLaiMember 2021-05-06 0001809616 2021-05-06 0001809616
2021-05-01 2021-05-06 0001809616
upc:JiangxiLulingRuralCommercialBankMember 2021-06-16 0001809616
upc:JiangxiLulingRuralCommercialBankMember 2021-06-01 2021-06-16
0001809616 2021-06-01 2021-06-16 0001809616 2021-06-16 0001809616
2021-06-30 0001809616 2021-06-01 2021-06-30 0001809616 2021-03-18
0001809616 2021-03-01 2021-03-18 0001809616
upc:MaturityGreaterThan90DaysOneMember 2022-03-31 0001809616
upc:MaturityGreaterThan90DaysOneMember 2021-09-30 0001809616
upc:MaturityGreaterThan90DaysTwoMember 2022-03-31 0001809616
upc:MaturityGreaterThan90DaysTwoMember 2021-09-30 0001809616
upc:MaturityGreaterThan90DaysThreeMember 2022-03-31 0001809616
upc:MaturityGreaterThan90DaysThreeMember 2021-09-30 0001809616
upc:MaturityGreaterThan90DaysFourMember 2022-03-31 0001809616
upc:MaturityGreaterThan90DaysFourMember 2021-09-30 0001809616
upc:MrGangLaiMember 2021-10-01 2022-03-31 0001809616
upc:MsLinYangMember 2021-10-01 2022-03-31 0001809616
upc:GreatestGroupMember 2021-10-01 2022-03-31 0001809616
upc:FoshanShangyuMember 2021-10-01 2022-03-31 0001809616
upc:GreatestGroupMember 2022-03-31 0001809616
upc:GreatestGroupMember 2021-09-30 0001809616
upc:FoshanShangyuMember 2022-03-31 0001809616
upc:FoshanShangyuMember 2021-09-30 0001809616 upc:MrGangLaiMember
2022-03-31 0001809616 upc:MrsLinYangMember 2021-09-30 0001809616
country:HK 2021-10-01 2022-03-31 0001809616 country:HK 2020-10-01
2021-03-31 0001809616 country:KY 2021-10-01 2022-03-31 0001809616
country:KY 2020-10-01 2021-03-31 0001809616 country:CN 2021-10-01
2022-03-31 0001809616 country:CN 2020-10-01 2021-03-31 0001809616
upc:CustomerMember 2021-10-01 2022-03-31 0001809616
upc:CustomerMember 2020-10-01 2021-03-31 0001809616
upc:TotalRevenueMember 2021-10-01 2022-03-31 0001809616
upc:TotalRevenueMember 2020-10-01 2021-03-31 0001809616
upc:GubenYanlingPillMember 2021-10-01 2022-03-31 0001809616
upc:GubenYanlingPillMember 2020-10-01 2021-03-31 0001809616
us-gaap:AccountsReceivableMember 2021-10-01 2022-03-31 0001809616
us-gaap:AccountsReceivableMember 2020-10-01 2021-09-30 0001809616
upc:SupplierOneMember 2021-10-01 2022-03-31 0001809616
upc:SupplierTwoMember 2021-10-01 2022-03-31 0001809616
upc:SupplierOneMember 2020-10-01 2021-09-30 0001809616
upc:SupplierTwoMember 2020-10-01 2021-09-30 0001809616
upc:supplierMember 2021-10-01 2022-03-31 0001809616
upc:SupplierOneMember 2020-10-01 2021-03-31 0001809616
upc:SupplierTwoMember 2020-10-01 2021-03-31 0001809616
upc:SupplierThreeMember 2020-10-01 2021-03-31 0001809616
upc:UniverseINCMember 2022-03-31 0001809616 upc:UniverseINCMember
2020-08-07 0001809616 upc:UniverseINCMember 2020-08-02 2020-08-07
0001809616 upc:UniverseINCMember us-gaap:CommonStockMember
2021-10-01 2022-03-31 0001809616 us-gaap:IPOMember 2021-03-25
0001809616 us-gaap:IPOMember 2021-03-29 0001809616
us-gaap:IPOMember 2021-03-25 2021-03-25 0001809616
us-gaap:IPOMember 2022-03-31 0001809616 us-gaap:IPOMember
2021-09-30 0001809616 upc:UnderwriterWarrantsMember 2022-03-31
0001809616 upc:UnderwriterWarrantsMember 2021-10-01 2022-03-31
0001809616 upc:UnderwriterWarrantsMember us-gaap:IPOMember
2022-03-31 0001809616 upc:UnderwriterWarrantsMember 2022-03-31
0001809616 upc:CashDividendsMember 2016-09-02 2016-09-21 0001809616
upc:CashDividendsMember 2017-09-02 2017-09-13 0001809616
upc:CashDividendsMember 2018-01-28 2018-02-02 0001809616
upc:CashDividendsMember 2018-09-02 2018-09-20 0001809616
upc:CashDividendsMember 2019-02-02 2019-02-21 0001809616
upc:CashDividendsMember 2021-10-01 2022-03-31 0001809616
upc:StatutoryReserveAndRestrictedNetAssetsMember 2021-10-01
2022-03-31 0001809616
upc:StatutoryReserveAndRestrictedNetAssetsMember 2022-03-31
0001809616 upc:StatutoryReserveAndRestrictedNetAssetsMember
2021-09-30 0001809616
upc:StatutoryReserveAndRestrictedNetAssetsMember 2020-10-01
2021-09-30 0001809616 upc:PRCMember 2022-03-31 0001809616
upc:PRCMember 2021-03-31 0001809616 pf0:ChiefExecutiveOfficerMember
2021-10-01 2022-03-31 0001809616 us-gaap:CorporateMember 2021-10-01
2022-03-31 0001809616 us-gaap:CorporateMember 2020-10-01 2021-03-31
0001809616 upc:CorporateSegmentOneMember 2021-10-01 2022-03-31
0001809616 upc:CorporateSegmentOneMember 2020-10-01 2021-03-31
0001809616 upc:CorporateSegmentTwoMember 2021-10-01 2022-03-31
0001809616 upc:CorporateSegmentTwoMember 2020-10-01 2021-03-31
0001809616 upc:CorporateSegmentThreeMember 2021-10-01 2022-03-31
0001809616 upc:CorporateSegmentThreeMember 2020-10-01 2021-03-31
0001809616 upc:CorporateSegmentFourMember 2021-10-01 2022-03-31
0001809616 upc:CorporateSegmentFourMember 2020-10-01 2021-03-31
0001809616 upc:CorporateSegmentFiveMember 2021-10-01 2022-03-31
0001809616 upc:CorporateSegmentFiveMember 2020-10-01 2021-03-31
0001809616 upc:CorporateSegmentSixMember 2021-10-01 2022-03-31
0001809616 upc:CorporateSegmentSixMember 2020-10-01 2021-03-31
0001809616 pf0:ScenarioForecastMember upc:LRCBankMember 2022-06-15
0001809616 pf0:ScenarioForecastMember upc:LRCBankMember 2022-06-15
2022-06-15 0001809616 pf0:ScenarioForecastMember
upc:BankOfCommunicationsMember 2022-06-24 0001809616
pf0:ScenarioForecastMember upc:BankOfCommunicationsMember
2022-06-24 2022-06-24 0001809616 us-gaap:ParentMember 2022-03-31
0001809616 us-gaap:ParentMember 2021-09-30 0001809616
us-gaap:ParentMember 2021-10-01 2022-03-31 0001809616
us-gaap:ParentMember 2020-10-01 2021-03-31 0001809616
us-gaap:ParentMember 2020-09-30 0001809616 us-gaap:ParentMember
2021-03-31 iso4217:USD iso4217:USD xbrli:shares xbrli:shares
xbrli:pure iso4217:CNY utr:sqm